Post PCI atrial fibrillation

Acute Cardiac Care

Volumn 9, Issue 2, 2007, Pages 69-76

  Kudaiberdieva, Gulmira ^a   Gorenek, Bulent ^b  

^a National Center of Cardiology and Therapy   (Kyrgyzstan)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Percutaneous coronary interventions

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HUMAN; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; SINUS RHYTHM;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL FIBRILLATION; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; SYNDROME; THROMBOLYTIC THERAPY;

EID: 34250727151     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940600990285     Document Type: Review

References (58)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-52.
2. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37:371-8.
3. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:1303-9.
4. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:406-13.
5. Wong CK, White HD, Wilcox RG, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878-85.
6. Pizzetti F, Turazza FM, Franzosi MG, et al.; GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86:527-32.
7. Eldar M, Canetti M, Rotstein Z, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation. 1998;97:965-70.
8. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS; OPTIMAAL investigators. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J. 2005;26:350-6.
9. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J. 1999;20:748-54.
10. Asanin M, Perunicic J, Mrdovic I, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail. 2005;7:671-6.
11. Sakata K, Kurihara H, Iwamori K, et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol. 1997;80:1522-7.
12. Sugiura T, Iwasaka T, Takahashi N, et al. Factors associated with atrial fibrillation in Q wave anterior myocardial infarction. Am Heart J. 1991;121:1409-12.
13. Hod H, Lew AS, Keltai M, et al. Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation. 1987;75:146-50.
14. Kyriakidis M, Barbetseas J, Antonopoulos A, Skouros C, Tentolouris C, Toutouzas P. Early atrial arrhythmias in acute myocardial infarction. Role of the sinus node artery. Chest. 1992;101:944-7.
15. Al-Shanafey S, Dodds L, Langille D, Ali I, Henteleff H, Dobson R. Nodal vessels disease as a risk factor for atrial fibrillation after coronary artery bypass graft surgery. Eur J Cardiothorac Surg. 2001;19:821-6.
16. Tjandrawidjaja MC, Fu Y, Kim DH, Burton JR, Lindholm L, Armstrong PW; CAPTORS II Investigators. Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. J Electrocardiol. 2005;38:271-8.
17. Mehta RH, Dabbous OH, Granger CB, et al.; GRACE Investigators. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031-6.
18. Al-Khatib SM, Pieper KS, Lee KL, et al. Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. Am J Cardiol. 2001;88:76-9.
19. Kassem-Moussa H, Mahaffey KW, Graffagnino C, et al.; SYMPHONY and 2nd SYMPHONY Investigators. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. Am Heart J. 2004;148:439-46.
20. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673-9.
21. Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-4.
22. Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/ atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150-4.
23. Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am Heart J. 2002;143:519-27.
24. Pedersen OD, Abildstrom SZ, Ottesen MM, et al. TRACE Study Investigators. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J. 2006;27:290-5.
25. Laurent G, Zeller M, Dentan G, et al. Prognostic impact of new onset atrial fibrillation in acute non-ST elevation myocardial infarction data from the RICO survey. Heart. 2005;91:369-70.
26. Mehta RH, Harjai KJ, Grines L, et al. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol. 2004;43:1765-72.
27. El-Omar MM, Dangas G, Mehran R, et al. Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. Am J Cardiol. 2003;91:232-4.
28. Cheng CI, Yeh KH, Chang HW, et al. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest. 2004;126:47-53.
29. Schoonderwoerd BA, Van Gelder IC, Crijns HJ. Left ventricular ischemia due to coronary stenosis as an unexpected treatable cause of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:224-8.
30. Bunc M, Starc R, Podbregar M, Brucan A. Conversion of atrial fibrillation into a sinus rhythm by coronary angioplasty in a patient with acute myocardial infarction. Eur J Emerg Med. 2001;8:141-5.
31. Avezum A, Makdisse M, Spencer F, et al. GRACE Investigators. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005;149:67-73.
32. Sugiura T, Nakamura S, Kudo Y, Okumiya T, Yamasaki F, Iwasaka T. Clinical factors associated with persistent pericardial effusion after successful primary coronary angioplasty. Chest. 2005;128:798-803.
33. Aboufakher R, Riba A, Jani SM, et al. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J. 2005;150:455-8.
34. Roe MT, Mahaffey KW, Kilaru R, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004;25:313-21.
35. Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple Electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135:733-8.
36. Gorenek B, Kudaiberdieva G, Cavusoglu Y, et al. Immediate recurrence of atrial fibrillation after internal cardioversion: importance of right atrial conduction variations. J Electrocardiol. 2002;35:313-20.
37. Gialafos JE. P-wave dispersion. Eur Heart J. 1999;20:317. 38. Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sinus sick node syndrome. J Am Coll Cardiol. 1991;17:403-8.
38. Centurion OA, Isomoto S, Fukatani M, et al. Relationship between atrial conduction defects and fractioned atrial endocardial electrocardiograms in patients with sick sinus syndrome. Pacing Clin Electrophysiol. 2002;16:2022-3.
39. Papageoriou P, Monahan K, Boyle NG, et al. Site dependent intra-atrial conduction delay: Relationship to initiation of atrial fibrillation. Circulation. 1996;94:348-9.
40. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;88:2618-22.
41. Vilani GQ, Piepoli M, Cripps T, et al. Atrial late potentials in patients with paroxysmal atrial fibrillation detected using a high gain, signal-averaged esophageal lead. Pacing Clin Electrophysiol. 1994;17:1118-23.
42. Klein M, Evans SJL, Cataldo L, et al. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1995;129:895-901.
43. Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J. 1999;20:211-20.
44. Aytemir K, Aksoyek S, Y?ld?r?r A, et al. Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography. Int J Cardiol. 1999;70:15-21.
45. Ozmen F, Atalar E, Aytemir K, et al. Effect of balloon-induced acute ischemia on P wave dispersion during percutaneous transluminal coronary angioplasty. Europace. 2001;3:299-303.
46. Batur MK, Yildirir A, Onalan O, Kabakci G, Tokgozoglu L, Oto A. Angioplasty induced myocardial ischaemia prolongs the signal-averaged P-wave duration in single vessel coronary artery disease. Europace. 2002;4:289-93.
47. Budeus M, Hennersdorf M, Dierkes S, et al. Effects of right coronary artery PTCA on variables of P-wave signal averaged electrocardiogram. Ann Noninvasive Electrocardiol. 2003;8:150-6.
48. Akdemir R, Ozhan H, Gunduz H, et al. Effect of reperfusion on P-wave duration and P-wave dispersion in acute myocardial infarction: primary angioplasty versus thrombolytic therapy. Ann Noninvasive Electrocardiol. 2005;10:35-40.
49. Celik T, Iyisoy A, Kursaklioglu H, et al. Effects of primary percutaneous coronary intervention on P wave dispersion. Ann Noninvasive Electrocardiol. 2005;10:342-7.
50. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588-636.
51. Eldar M, Canetti M, Rotstein Z, Boyko V, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation. 1998;97:965-70.
52. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337:1118-23.
53. Harjai KJ, Boura J, Grines L, et al. Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarction. Am J Cardiol. 2002;90:1193-7.
54. Bonnemeier H, Ortak J. Reperfusion associated cardioversion of atrial fibrillation in acute myocardial infarction. Ann Noninvasive Electrocardiol. 2005;10:224-5.
55. Gorenek B, Birdane A, Unalir A, et al. Restoring sinus rhythm in patients with atrial fibrillation complicating acute myocardial infarction: comparison of outcomes of primary angioplasty and thrombolytic therapy. Eur J Heart Fail. 2000;Suppl 1:32 (abstract).
56. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet. 1997;350:1417-24.
57. Wong CK, White HD, Wilcox RG, et al. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Heart. 2002;88:357-62.
58. Camm AJ, Pratt CM, Schwartz PJ, et al. AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation. 2004;109:990-6.